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Chagas disease, characterized by acute myocarditis and chronic cardiomyopathy, is caused by infection with the protozoan parasite Trypanosoma
cruzi. We sought to identify genes altered during the development of parasite-induced cardiomyopathy. Microarrays containing 27,400 sequence-
verified mouse cDNAs were used to analyze global gene expression changes in the myocardium of a murine model of chagasic cardiomyopathy.
Changes in gene expression were determined as the acute stage of infection developed into the chronic stage. This analysis was performed on the hearts
of male CD-1 mice infected with trypomastigotes of T. cruzi (Brazil strain). At each interval we compared infected and uninfected mice and confirmed
the microarray data with dye reversal. We identified eight distinct categories of mRNAs that were differentially regulated during infection and identified
dysregulation of several key genes. These data may provide insight into the pathogenesis of chagasic cardiomyopathy and provide new targets for
intervention.
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doi:10.1016/j.ygeno.2008.01.008and insect vectors. The vectors become infected after taking
bloodmeals from infectedmammalian hosts that have circulating,
nondividing, blood-form trypomastigotes (BFTs), which trans-
form into epimastigotes, which multiply extracellularly in the
insect midgut and then differentiate into nondividing metacyclic
trypomastigotes (MTs). MTs enter the host during the insect’s
next blood meal and transform into BFTs that in turn penetrate
mammalian cells, transform into amastigotes, and multiply
424 S. Mukherjee et al. / Genomics 91 (2008) 423–432intracellularly. Amastigotes fill the host cell and differentiate into
BFTs, which are then released as the host cell ruptures and invade
adjacent tissues and spread via the lymph and blood to distant sites
where they undergo further cycles of intracellular multiplication.
In this way, the human host maintains a parasitemia infective for
vectors, thus completing the transmission cycle. T. cruzi also may
be transmitted by blood transfusion, laboratory accidents, and
organ transplantation and from mother to fetus [1].
Ten to thirty percent of T. cruzi-infected individuals even-
tually progress to a chronic cardiomyopathy, the etiology of
which is multifactorial [2], including parasite persistence, mi-
crovascular spasm, and focal ischemia [1,3–6]. T. cruzi infects a
variety of cells in the cardiovascular system, including endo-
thelial cells, smooth muscle cells, cardiac myocytes (CMs), and
cardiac fibroblasts, resulting in inflammation and cardiac re-
modeling. The parasite gains access to CMs by invading endo-
thelial cells and then the interstitial areas of the vascular and
myocardial wall. Trypomastigotes traverse the basal laminae
areas and the extracellular matrix, which is damaged as a result
of parasite proteases and collagenases and through contribu-
tions from the host inflammatory response [7]. Remodeling of
the myocardium ensues with replacement of CMs and/or vas-
cular cells by fibrous tissue. These events result in thinning of
the myocardium and hypertrophy of the remaining CMs. There
is cellular proliferation in the myocardium involving inflam-
matory cells, fibroblasts, endothelial cells, and smooth muscle
cells. These irreversible changes eventually lead to functional
disturbances [8,9]. In addition, although commonly considered
to be terminally differentiated, CMs can be induced to proli-
ferate through the increased expression of cell cycle regulatory
proteins such as the D cyclins, resulting in cell cycle pro-
gression and cell division [10].
The mouse model of T. cruzi infection recapitulates many of
the functional and pathological alterations of the human disease.
In the myocardia of acutely infected mice, the inflammatory
reaction is characterized by the presence of numerous pseudo-
cysts together with increased tissue expression of inflammatory
mediators and components of the endothelin-1 (ET-1) pathway
[6,11,12]. Additionally, plasma levels of the inflammatory me-
diators [13], ET-1 [6], and thromboxane A2 [14,15] are elevated.
As the acute stage subsides, the intermediate and chronic stages
ensue. Chronic chagasic cardiomyopathy in mice is character-
ized by dilated cardiomyopathy associated with a reduction in
fractional shortening and myocardial wall thinning [16]; both
observations are consistent with those described in human
chagasic cardiomyopathy. The factors that contribute to the
progression from acute to chronic cardiac disease are not well
understood.
DNA microarrays provide a powerful technique for profiling
genome-wide gene expression, allowing the assessment of the
levels of expression of thousands of mRNA transcripts simul-
taneously. This technology has been utilized to understand the
pathogenesis of infectious cardiomyopathy [17] and cancer
[18]. Moreover, microarray technology has been applied to the
identification of genes that are altered in the heart in T. cruzi
infection [19–21]. In the current project, we have extended our
previous studies [21] and examine transcriptome changes inCD-1 mice infected with the Brazil strain of T. cruzi through the
various stages of the disease. The patterns of gene expression
during the development of murine chagasic heart disease,
encompassing several time points in the transition from acute to
chronic disease, are reported.
Results and discussion
Gene profiling using microarray technology has become an
important tool for identifying genes whose expression is altered in
various disease states, notably in cancer and cardiovascular dis-
eases [17,18]. Microarrays are used to characterize the expression
of thousands of genes from a single hybridization. The results of
these types of investigations may yield data identifying pathways
involved in the pathogenesis of particular diseases. In addition,
results of this type may provide novel targets for chemotherapy.
Microarray analyses have been performed in experimentalmodels
having a variety of cardiac diseases and on limited human speci-
mens, including cardiomyopathy, congestive heart failure, myo-
cardial ischemia, and heart transplant rejection [19–23].
When CD-1 male mice are infected with the Brazil strain of
T. cruzi, 40 to 50% of the mice die by day 35 to 45 postinfection
(p.i.). The remaining mice displayed an evolution to a chronic
stage. The validation of this model is derived in part from cardiac
magnetic resonance imaging (MRI) and pathological data we
have previously published demonstrating that T. cruzi-infected
mice develop a dilated cardiomyopathy by 100–120 days p.i.
[24–27]. The goal of the current investigation was to identify, in
a mouse model, genes whose expression is substantively altered
during the development of chagasic cardiomyopathy.
The current investigation is novel because it is a longitudinal
study in a well-validated model of the human disease in a mouse.
This is among the first studies to examine the global transcrip-
tional profile encompassing various time points during the pro-
gression from the acute to the chronic stage. In this study we used
a high-density microarray containing 27,400 sequence-verified
mouse cDNAs to assess the changes in gene expression during
T. cruzi infection in cardiac tissue. Since most of the mouse genes
have homologues in humans, the identification of changes in
murine genes could suggest molecular mechanisms involved in
the development of human chagasic cardiomyopathy.
Hierarchical clustering of genes
We used the Cluster and TreeView software [47] to generate
dendrograms representing changes in gene expression for six time
points, 30, 60, 90, 120, 150, and 180 days p.i. This cluster analysis
generated a list of 7000 genes, expression values of which were
quantifiable at at least three time points. The hierarchical cluster
analysis revealed variability in the patterns of gene expression in
the infected heart as the disease progressed (Fig. 1A). The
observed pattern of gene expression clearly identified three
distinct stages, and we considered mice 30 to 60 days p.i. to be in
the “acute” or “subacute” stage of infection, those between 60 and
90 days p.i. in the “intermediate” stage, and those from 90 to 180
days p.i. in the “chronic” stage of infection. The intermediate
stage may be similar to the “indeterminate” stage described in
Fig. 1. Hierarchical cluster analysis of differentially expressed genes in the heart. (A) The cluster analysis generated a list of 7000 genes whose expression values were
recorded at at least three time points. The size of the node indicates the number of genes it contains. Eight distinct classes were observed. (B) Genes that were down
regulated at all time points. (C) Genes that were down regulated in subacute and acute stages (30–60 days p.i.). (D) Genes that were down regulated in the chronic stage
(150–180 days p.i.). (E) Genes that were down regulated in the intermediate stage (90–120 days p.i.). (F) Genes that showed fluctuating expression throughout the
time points. (G) Genes up regulated at all time points. (H) Genes up regulated in the chronic stage (150–180 days p.i.). (I) Genes that were down regulated in the acute
stage but up -regulated in the chronic stage. Red indicates up regulation of gene expression, green indicates down regulation, black indicates intermediate expression,
while gray indicates missing values at that time point. The gene names are given on the right.
425S. Mukherjee et al. / Genomics 91 (2008) 423–432human disease. This classification is not arbitrary because it is
based on reports from our laboratory validated by pathology,
echocardiography, and cardiac MRI [24–27].
We classified gene expression into eight classes, depending on
stage-specific gene expression. We identified 9 genes that were
down regulated throughout the entire time course, in comparison
to uninfected controls; these included laminin γ 2, epsin 2,
cathepsin L, and fibroblast growth factor 1 (Fig. 1B). A total of 11
genes were down regulated in the subacute or acute stage,
including those of mitogen-activated protein kinase, adducin-3 γ,
crystallin γ, tight junction protein 1, and procollagen type-1 α-1
(Fig. 1C). Five genes were down regulated in the chronic stage,
including presenilin 2, inalose 2 (β muscle), spindlin, aldolase 3
(β isoform), and formin-binding protein 3 (Fig. 1D). Three genes
that were down regulated in the intermediate stage (Fig. 1E) were
cytochrome P450 (4a14), growth factor receptor-bound protein 7,
and thymic epithelial cell surface antigen. There were 16 genes
that showed fluctuating expression throughout the time points.For example, genes in this category included cytochrome P450
[2d9, III A2, 2e1 (ethanol inducible)], coagulation factors II and
IX, protein C, hepatic lipase, and α1 microglobulin (Fig. 1F).
There were 17 genes related to immunity that were consis-
tently up regulated during the entire time course (Fig. 1G). In the
chronic stage 16 geneswere up regulated, including those encoding
γ-fibrinogen, coagulation factor II, transthyretin, microglobulin 2,
cytochrome P450 (steroid inducible), and α2 macroglobulin
(Fig. 1H). We also found 9 genes that were down regulated in
the acute stage but were up regulated in the chronic stage. These
genes include those for annexin V, calpain 5, vanin 3, phos-
pholipase D3, and CD48 antigen (Fig. 1I).
Inflammatory mediator genes
Several genes involved in immune responses to T. cruzi
infection were altered. For example, we found that immune
system and histocompatibility class II genes were up regulated.
426 S. Mukherjee et al. / Genomics 91 (2008) 423–432Small inducible cytokines (A6, A19, subfamily B, and sub-
family D) were considerably up regulated 30–60 days p.i. and
maintained to 90 days p.i., thus indicating that T. cruzi infection
results in an up regulation of the inflammatory response. Be-
yond these time points, their expression was similar to that in
the uninfected controls (Table 1A).
Transcriptional up regulation of chemokine receptors CCR2
and CCR5 and CXCR4 was observed during acute infection and
decreased thereafter (Table 1B). We also validated the up reg-
ulation of CCR5 by immunoblotting and observed that its
expression was significantly increased at days 90 and 120 p.i. in
infected mouse hearts (Fig. 3). Expression of CCR5 is
indicative of Th1 responses and its up regulation is consistent
with the observations of Machado et al. [28]. We could not
detect alterations of IFN-γ transcripts nor was there any sig-
nificant change in IFN regulatory factors 2 and 3 (data not
shown). However, IFN regulatory factors 1 and 5 were up reg-
ulated at 30 days p.i. by 2.6- and 3.2-fold, respectively, but at all
other time points their expression was not significantly changed
compared to controls (Table 1C). IFN-γ-induced GTPase, an
important defense against intracellular pathogens, was con-
siderably up regulated at 30–90 days p.i. (Table 1C).
T. cruzi synthesizes a 52-kDa protein (Tc52) that suppresses
T cell proliferation [29] and acts as a cytokine stimulating nitricTable 1
Name Accession No. 30 d
(A) Small inducible cytokine A3 AA071899 2.5
Small inducible cytokine A4 AA178155 4.6
Small inducible cytokine A6 AA119293 8.6
Small inducible cytokine A12 AA286393 1.8
Small inducible cytokine A19 AA444730 1.5
Small inducible cytokine B subfamily AA472492 15.3
(B) Chemokine (C-C) receptor 2 AA289476 2.2
Chemokine (C-C) receptor 5 AA144482 6.3
Chemokine (C-X-C) receptor 4 W88094 4.7
(C) Interferon regulatory factor 1 C85224 2.5
Interferon regulatory factor 5 AA185025 3.2
Interferon-γ-induced GTPase AA178613 7.6
(D) Interleukin 12b AA267353 0.8
Interleukin 16 C85263 1.3
Interleukin 4 AA199406 1.0
Interleukin 1 receptor, type 1 AA177717 2.7
Interleukin 2 receptor, γ chain AA274104 4.3
Interleukin 4 receptor, α AA166418 2.2
Interleukin 15 receptor, α chain AA276366 2.3
(E) Fibroblast growth factor 1 AA261582 0.2
Fibroblast growth factor 10 C78836 0.4
Fibroblast growth factor 12 AI415248 2.5
Fibroblast growth factor 15 AA051675 1.5
Fibroblast growth receptor 1 AI326934 1.8
Fibroblast growth receptor 2 AW556123 0.8
Fibroblast growth receptor 3 AI413661 7.1
Fibroblast growth receptor 4 AI385693 0.9
Transforming growth factor, β 2 W53962 1.6
Transforming growth factor, β receptor AA124340 1.6
Epidermal growth factor receptor pathway AW556306 3.3
Epidermal growth factor receptor AA237224 1.0
Platelet-derived growth factor receptor AA270169 2.0
Secretory leukocyte protease inhibitor AA200339 6.2
Prostaglandin E receptor 1 (EP1) W99842 2.7oxide production in macrophages [30]. Tc52 modulates several
interleukin genes such as IL-1α, IL-12, and IL-10 [29]. We
observed that IL-16 was up regulated throughout the infection,
while IL-4 and IL-12 were up regulated only in the intermediate
stage and all three interleukins returned to baseline level during
the chronic stage of infection (Table 1D). Receptors for IL-1β
(type 1), -2 (γ chain), -4 (α), and -15 (α) were expressed at a
very high level during the acute stage; the expression of the IL-2
receptor γ chain was increased at all time points p.i. The other
interleukin receptors returned to baseline values during chronic
infection (Table 1D). The increase in the activation of the IL-2
receptor gene could be the result of the down regulation of IL-2
production [31]. Secretory leukocyte protease inhibitor (SLIPI)
is a modulator of the inflammatory response [32,33]. During
acute infection there was a greater than sixfold increase in SLIPI
gene expression, which waned as the infection became chronic
(Table 1E).
Growth factor genes
There was a significant increase in the expression of fibro-
blast growth factor genes (12 and 15) and fibroblast growth
factor receptor genes (3 and 1) (Table 1E). FGFs 15 and 12 were
also up regulated at 30 days p.i., while FGFs 1 and 10 wereays 60 days 90 days 120 days 150 days 180 days
7 1.20 1.23 1.02 1.06 0.99
5 3.22 2.44 1.10 1.32 1.53
8 1.34 1.20 1.22 1.10 0.98
6 1.78 1.82 0.74 0.79 0.64
8 2.39 1.71 0.89 1.00 1.18
6.25 1.28 0.86 1.04 1.03
1 2.14 1.80 1.05 0.96 0.42
8 4.32 2.25 1.36 1.09 1.05
9 2.65 1.23 1.18 1.14 0.84
8 1.04 1.42 0.95 1.08 0.96
6 2.15 1.52 1.52 1.12 1.31
8 3.48 2.63 1.07 0.76 0.89
4 1.52 1.14 1.48 1.02 0.91
1 1.30 1.50 1.11 1.11 1.20
1 0.80 1.26 1.17 1.14 1.04
2 0.66 1.10 0.98 1.00 1.04
1 1.56 2.07 1.63 1.56 1.55
4 0.82 1.03 1.03 1.01 0.98
4 0.82 1.17 1.54 0.77 1.10
0 0.50 0.70 0.80 1.17 1.07
6 0.84 1.35 1.04 1.18 1.16
5 0.93 1.18 1.26 1.05 0.87
2 1.10 0.93 1.05 1.12 1.04
8 0.75 1.40 1.02 1.11 0.88
7 1.57 1.06 0.91 1.35 0.90
5 1.50 1.29 1.05 1.02 0.88
8 1.49 1.05 0.86 0.56 0.95
2 0.68 1.19 1.23 1.07 1.07
4 0.71 0.95 0.93 0.57 0.69
9 0.74 1.09 1.08 0.93 0.97
3 0.63 1.71 1.61 0.83 0.89
3 0.56 1.43 1.37 1.44 1.07
1 2.58 1.31 1.11 0.98 0.91
9 0.71 0.83 1.46 1.53 1.13
427S. Mukherjee et al. / Genomics 91 (2008) 423–432down regulated during the acute stage. FGF receptor 3 was
more highly expressed during acute infection compared with the
other receptors. There was an up regulation of transforming
growth factor (TGF) β-2, β-receptor, and epidermal growth
factor (EGF) receptor pathways and PGDF receptor genes
during acute infection (Table 1E). We validated up regulation of
both EGF receptor and TGF β genes by real-time polymerase
chain reaction (qPCR) (Table 3).
Cell cycle and apoptotic genes
Previously, we reported that T. cruzi infection leads to the
proliferation of fibroblasts, endothelial cells, and smooth mus-
cle cells by the activation of the Ras–Raf–ERK cascade [34]
associated with activation of cyclin D1. Here we confirm our
previous studies and also show that cyclin E, cyclin-dependent
kinase (cdk) 4, and cdc25A are significantly up regulated during
acute infection (Fig. 2D). The cyclin E gene was up regulated at
30 days p.i. and continued through 120 days p.i. (1.5-fold). At
150 and 180 days p.i., cyclin E expression returned to baseline,
while the expression of cyclin D2 increased in the chronic stage.
We validated cyclin D1 expression by qPCR and both cyclin D2
and cyclin E by immunoblot analysis (Fig. 3). We observedFig. 2. Expression of apoptotic and cell division genes in T. cruzi infection in murine
regulated during the acute stage. The cyclin E gene was overexpressed during the acutconsiderable cyclin E during the acute stage and cyclin D2
during the chronic stage (Fig. 3A), indicating an increase in
proliferative changes in heart tissues as the disease progressed
to the chronic stage. Thus, in the current study, we confirmed
our previous observation that T. cruzi infection leads to major
proliferative changes in the infected heart by up regulating not
only D-type cyclins [34–36], but also cyclin E, cdk 4, and
cdc25A during acute infection. Cyclin D2 is required for
induction of the adult CM cell cycle reentry [10] and cyclin
D2 induction promoted proliferation but not hypertrophy. Our
demonstration that cyclin D2 expression was highest during the
chronic stage suggests that adult mouse myocardial cells revert
to a proliferative phenotype, as opposed to hypertrophy, fol-
lowing prolonged T. cruzi infection. Additional experiments
will be performed to address this possibility. Cyclin E is not
ordinarily observed in normal adult heart but rather in fetal and
neonatal heart. Thus this infection appears to cause a reversion
to a fetal/neonatal phenotype.
The expression of several proapoptotic genes, including
caspases 1 and 11 (similar to human caspase 4), was signifi-
cantly up regulated in the acute stage. These caspases induce
inflammation and when overexpressed may lead to apoptosis.
Caspase 2 and caspase 12 were not overexpressed; indicatingheart. Proapoptotic genes like caspases 1 and 11 and Fas antigen ligand were up
e stage, while cyclin D2 was overexpressed during the chronic stage of infection.
Fig. 3. (A) Immunoblot demonstrating that expression of cyclin E was increased during early infection but then returned to baseline values. Cyclin D2 and caspase 12
increased during the chronic stage of infection. The expression of the chemokine receptor CCR5 is increased by 90–120 days p.i. (B) Representative cardiac MRI
demonstrating increased right ventricular internal diameter (RVID, *). (C) Quantitative data demonstrating that there is an increase in RVID in mice at 120 days p.i.
428 S. Mukherjee et al. / Genomics 91 (2008) 423–432that nuclear lamins were not affected by infection (caspase 2) and
endoplasmic reticulum-induced stress was not involved in the
apoptosis of infected cardiac myocytes. We also verified by
immunoblotting that caspase 12 protein levels remained un-
changed (Fig. 3A). Previously, it had been reported that lym-
phocyte activation by apoptosis induced cell death [37–39],
occurring as a result of Fas–Fas-L interaction. Interestingly, we
observed that Fas antigen ligand was overexpressed more thanFig. 4. (A) Fas-L and (B) Fas expression was determined on cultured CMs. CMs w
harvested and labeled with antibodies specific for Fas and Fas-L and subjected to flo
three separate experiments. ⁎pb0.05, compared with the values obtained in the absen
followed by the Student–Newman–Keuls test.3.5-fold in the acute stage, but it is unclear if the origin of the
observed activation was lymphocytes or CMs.
To validate the induction of Fas–Fas-L in CMs by T. cruzi,we
examined the expression of Fas–Fas-L on infected cultured CMs.
As can be seen in Fig. 4, there was no significant increase in Fas
expression on the CMs in the control group but constitutively
expressed Fas-L on their surfaces. After infection, CMs displayed
increased Fas expression and decreased expression of Fas-L onere cultured with medium only or with trypomastigote forms. The cells were
w-cytometry analysis. The results are the means (±SD) of triplicate samples of
ce of T. cruzi. Statistical analysis was performed by use of analysis of variance,
Table 2
Name Accession
No.
30
days
60
days
90
days
120
days
150
days
180
days
Myosin heavy chain,
cardiac muscle
AA003252 1.06 3.50 0.90 0.98 0.82 0.94
Myosin heavy chain,
skeletal muscle
AA008698 0.83 1.10 0.86 1.28 1.05 1.00
Myosin Ib AA387258 0.10 0.81 0.86 0.94 0.67 0.98
Myosin Ic AW543748 1.41 0.76 1.06 1.26 0.86 0.97
Myosin light chain 2 AA032362 0.48 1.05 0.80 0.91 1.02 1.28
Myosin light chain, alkali,
cardiac atrium
C76805 1.39 1.36 0.92 0.91 0.93 0.88
Myosin Va W80031 1.67 0.94 1.09 0.86 0.96 0.99
Myosin Vb AW546331 0.90 0.98 0.86 1.21 1.21 1.04
Tropomyosin 2, β AW548955 1.23 0.81 0.88 1.83 0.85 1.20
Tropomyosin 5 AW545645 3.28 1.00 0.92 1.15 1.53 1.52
Tubulin α 2 AI894263 1.96 1.20 1.05 1.42 1.32 1.45
Tubulin α 4 AA435376 0.56 0.90 1.21 1.24 0.95 1.05
Tubulin β 2 AA061838 1.68 1.01 1.37 1.11 0.77 1.21
Tubulin β 4 AA222216 0.83 0.82 1.09 1.02 0.82 1.11
Tubulin β 5 W16254 1.58 0.88 1.73 0.92 0.98 0.96
Actin, α1, skeletal muscle AW539437 2.33 1.58 0.85 1.53 0.99 1.18
Actin, γ, cytoplasmic AW546793 0.86 0.71 0.90 1.21 1.01 1.03
Actin crosslinking
protein 7
W65621 0.94 0.46 1.19 1.41 1.22 0.98
Actinin α 2 AW556942 2.78 0.63 0.94 1.05 0.93 0.68
Actinin α 3 C86107 0.55 0.83 1.19 1.19 1.19 1.09
Catenin α 1 AW544339 1.01 0.49 0.76 0.81 0.94 0.96
Catenin α 2 AA049813 0.76 0.89 1.00 0.84 0.92 0.73
Catenin β AW537646 0.96 0.83 1.13 0.84 1.81 0.79
Catenin src C77281 0.71 1.10 0.87 0.90 1.25 1.09
Cadherin 2 AA034594 1.00 0.63 0.95 1.04 1.14 1.04
Cadherin 3 W12889 0.98 0.87 0.91 0.65 0.81 0.57
Cadherin 5 AA435117 1.20 0.84 1.07 0.74 0.61 0.69
Cadherin 16 AI449619 1.03 1.02 0.92 0.97 0.78 0.78
429S. Mukherjee et al. / Genomics 91 (2008) 423–432their surfaces. Fas-L constitutively expressed on the CMs could
play a major role in conferring an immune privilege by inducing
apoptosis in inflammatory cells that enter the heart, which is
similar to that which was reported for retinal cells [40]. The
infection-associated loss of Fas-L expression and increase in Fas
expression on CMs could explain in part the damage to CMs
during immune responses against the parasite. We are currently
investigating the role of the Fas–Fas-L pathway in myocardial
damage in this infection.
As stated, investigations on FAS and FAS-L in cultured CMs
were performed to validate our in vivo findings of a modulation
of the expression of these genes in the myocardium during
infection. We investigated the levels of surface expression of
Fas and Fas-L on infected and uninfected CMs. In a recent
report [41], Fas-L-deficient mice displayed less CM destruction
following T. cruzi infection. Our results indicated that there was
an increased level of Fas expression on T. cruzi-infected CMs.
Collectively these observations suggest that these cells become
the target for Fas-L-expressing cells and this may explain why
there is less CM destruction in Fas-L-deficient mice. Moreover,
our data demonstrate that naïve CMs constitutively express Fas-L,
but not Fas. This indicates that CMs can activate the Fas-
expressing cells that migrate to the heart and/or induce apoptosis
of these cells. Importantly, previous studies demonstrated that
Fas-based intracellular signaling is important for secretion of IL-
1β, IL-6, IL-17, IL-18, CCL3, CCL4, CXCL2, and IL-8 [42–44].
Thus, it is possible that the increased expression of Fas on infected
CMs may induce cell death and/or may be involved in the
activation of these cells to produce cytokines and chemokines that
in turn lead to cell death.
Several proapoptotic genes were significantly up regulated in
the acute stage. We could rule out the possibility of endoplasmic
reticulum-induced apoptosis during infection, since caspase 12
was not found to be overexpressed either at the transcription
or at the protein level. In addition, we also found that several
antiapoptotic genes like Bcl-2, Bcl-2-interacting protein, and
Bcl-2-associated athanogenes 2 and 3 (data not shown) were
overexpressed, indicating that infection does not disrupt mito-
chondrial Ca2+ homeostasis and even prevents mitochondrially
induced apoptosis. The expression of apoptosis-inhibitor pro-
teins 1–5 was up regulated during the acute stage, suggesting a
mechanism by which parasites may prevent cell death so that
the host can survive up to the chronic stage (Fig. 2C).
Cytoskeletal genes
We observed that both myosin heavy and light chain genes
were up regulated in the myocardium (Table 2) during the acute
stage. The expression of skeletal muscle myosin heavy chain
was not affected (Table 2). Myosins Va and 1c were up reg-
ulated, while myosin 1b was down regulated at 30 days p.i.
(Table 2). Tropomyosin 5 was significantly up regulated during
the acute stage (3.2-fold, 30 days p.i.), while tropomyosin 2 β
expression was variable during the time course, with increased
expression at 120 days p.i. (Table 2).
CMs are rich in cytoskeletal proteins such as tubulin and
actin. We observed an up regulation of various tubulin and actingenes during infection (Table 2). The up regulation of the
tubulin gene was validated by qPCR (Table 3, where numbers
indicate fold change). The expression of the actinin α 2 gene
was up regulated 30 days p.i., while catenin α, β, and src genes
along with cadherin 2, 3, 5, and 16 genes showed no substantive
changes during the time course.
Cardiac MRI
Chronic chagasic cardiomyopathy evolves into a dilated
cardiomyopathy in humans as well as in mice [24–27]. Here, we
report that there was a significant right ventricular enlargement
that was detected beginning at 90 days p.i. Fig. 3B shows a
representative cardiac MRI of an infected mouse 120 days p.i.
Note the enlargement of the right ventricle. Corresponding
quantitative data are presented in Fig. 3C. This confirms that the
microarrays were performed on mice that were developing a
cardiomyopathy as a consequence of infection.
In all cardiomyopathies there are structural abnormalities that
lead to functional abnormalities, including abnormal contraction
and relaxation. Dilated cardiomyopathy results from aberrant
expression of genes encoding contractile, cytoskeletal, and cal-
cium regulatory proteins, among many others. We have pre-
sented data regarding gene expression of cardiac contractile
genes, cytoskeletal genes, sarcomeric genes, and calcium reg-
ulatory genes in the hearts obtained from mice infected with
Table 3
Gene Real-time PCR Microarray
30 days 90 days 30 days 90 days
Cyclin D1 0.55 1.98 0.24 1.54
Prostaglandin E receptor 1 (EP1) 8.93 3.94 2.74 1.83
Epidermal growth factor receptor 1.65 2.54 1.03 1.71
Tubulin β 2 2.39 3.83 1.68 1.37
Transforming growth factor, β 2 2.36 1.98 1.64 0.95
Secretory leukocyte protease inhibitor 5.13 1.68 6.21 1.31
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(cardiac atria) genes were up regulated in the hearts of infected
mice and tropomyosin 2 βwas significantly up regulated as well
during the subacute and chronic stages, but not in the inter-
mediate stage. We also found up regulation of cytoskeletal
protein genes such as tubulin and actin during the subacute stage
of infection.
Comparison to other microarray studies
In our previous microarray study we examined the Brazil
strain-infected C7BL/6×129sv mouse at 100 days p.i. [21]. A
single cDNA slide (containing 27,000 mouse cDNAs), cross-
checked with dye reversal, revealed that there were 337 genes
that showed at least 1.5-fold expression variation with respect to
uninfected control. We classified regulated genes functionally
and observed that affected genes encode transcription factors, as
well as proteins associated with intracellular transport, signal-
ing, cytoskeleton and cell shape, and death. That study was
restricted to only one time point. The current study covers the
transcriptome changes of the entire spectrum of infection from
the acute to the chronic stage. Interestingly, in the previous
study we demonstrated up regulation of the gene for SLIPI,
which was validated by immunoblot. SLIPI is an important
modulator of inflammatory responses [32,33] responsible for
cardiac remodeling. In the present report using CD-1 mice we
observed a 6-fold increase in SLIPI expression during the acute
phase, which waned as the infection evolved into the chronic
phase.
Garg et al. [19] observed that among the most repressed
genes in their mouse model of chagasic heart disease were those
encoding troponins and oxidative phosphorylation complexes I
and IV. In the current study, we also observed repressed cy-
tochrome c oxidase polypeptide VIIc, cytochrome c oxidase
polypeptide ViaH, and NADH dehydrogenase (ubiquinone-1-α
subcomplex-1) genes in the chronic stage (see supplemental
data). In addition, data obtained by Cunha-Neto et al. [45] in
human chagasic cardiomyopathy (dilated cardiomyopathy) in-
dicated that genes for immunoglobulin k light chain, IFN-γ
receptor, and IFN consensus sequence DNA binding proteins
were up regulated in humans, and this was seen in our mouse
model as well.
This present longitudinal investigation is novel and con-
tinues to demonstrate the utility of gene expression profiling in
the examination of the initiation and progression of acute to
chronic chagasic heart disease and may provide useful targets
for the prevention of chronic chagasic cardiomyopathy.Materials and methods
Parasitology
The animal studies were approved by the IACUC of the Albert Einstein
College of Medicine. Five- to seven-week-old male CD-1 mice were infected
intraperitoneally with 5 × 104 trypomastigotes (Brazil strain). For each time
point five infected and five uninfected sex- and age-matched mice were used. In
the studies on infection of cultured embryonic CMs the Y strain was used.
Microarray hybridization, normalization, and filtering of the data
RNA extracted from five infected or control mice was pooled and purified
with the RNeasy midi kit (Qiagen, Valencia, CA, USA). Pooled RNA (100 μg)
was used for microarray analysis as described previously [21] (see supplemental
data for details). High-density cDNAmicroarrays containing 27,400 spotted and
sequence-verified cDNAs were obtained from the Albert Einstein College of
MedicineMicroarray Facility. We used two slides for each time point, one for the
forward and the other for the reverse labeling. Reverse labelingwas performed by
mixing equimolar amounts of oppositely labeled cDNAs (compared to forward
labeling) from the infected and uninfected hearts and hybridizing them to a
separate microarray slide [21]. Fluorescence intensity of the spots was nor-
malized using the Lowess normalization method available using the R statistical
package [46]. The genes that were differentially expressed were represented as a
ratio of intensity between the infected and the control samples as presented in the
paper and in the supplemental data. To generate the dendrogram, we considered
only those spots that had a normalized ratio greater than 1.5 (or less than 0.66 in
the flip array) and were represented at at least three time points.
Hierarchical cluster analysis
For cluster analyses, we took the average values from the forward and flip
arrays for all six time points. The average expression values were median
centered and log transformed. Finally we performed hierarchical cluster analysis
using the Gene Cluster program [47] obtained from http://rana.stanford.edu/
clustering. We used the Pearson correlation distance metrics and average linkage
for clustering organization. Only those genes that were represented at least twice
in the six time points were analyzed. The data generated from Cluster were
subjected to TreeView version 1.60 [47] to compute a dendrogram that as-
sembles all elements into a single tree.
Reagents
Antibodies to polyclonal cyclin D2 and cyclin E were obtained from Neo
Markers (Fremont, CA, USA). Antibodies to caspase 12, CCR5, andmonoclonal
β-actin antibody were obtained from Santa Cruz Biotechnology (Santa Cruz,
CA, USA). All other chemicals used in microarray were of the highest purity.
Immunoblot analysis
Immunoblot analysis was performed as previously described [48]. Primary
antibodies were used at a dilution of 1:500 and were probed with either anti-
rabbit HRP-conjugated secondary antibodies (for cyclin D2, CCR5) or anti-
rabbit AP-conjugated secondary antibodies (for cyclin E, caspase 12, β-actin) at
a dilution of 1:5000. For detection of β-actin, we used anti-mouse AP-
conjugated secondary antibodies at a dilution of 1:10,000. The bound primary
antibodies were visualized by ECL chemiluminescence (Amersham Bios-
ciences, Buckinghamshire, UK) when HRP-conjugated secondary antibodies
were used or by the BCIP/NBT color detection system (Promega, Madison, WI,
USA) for AP-conjugated secondary antibodies. For these experiments a Student
t test was performed and significance of difference was determined as pb0.05.
Real-time PCR analysis
To validate further the results obtained in the microarray analysis, the levels
of several genes were quantified by qPCR. Equal concentrations of total RNA
were reverse transcribed using oligo(dT) and Superscript II (Invitrogen) and the
431S. Mukherjee et al. / Genomics 91 (2008) 423–432qPCR was run in a thermocycler (iQ5 Bio-Rad) with the Fast Start Sybr Green
PCR master mix (Roche) following the manufacturer’s instructions. Thermo-
cycling was performed in a final volume of 20 μl containing 1 µl cDNA and 5
pmol of each primer (see supplemental data for primer sequences). To normalize
for gene expression, mRNA expression of the housekeeping gene hypoxanthine
phosphoribosyltransferase was measured. For every sample, both the house-
keeping and the target geneswere amplified in triplicate using the following cycle
scheme: After initial denaturation of the samples at 95 °C for 3 min, 40 cycles of
95 °C for 10 s and 55 °C for 30 s were performed. Fluorescence was measured in
every cycle, and a melting curve was analyzed after the PCR by increasing the
temperature from 55 to 95 °C (0.5 °C increments). A defined single peak was
obtained for all amplicons, confirming the specificity of the amplification.
Embryonic CM cultures
CMs were prepared as previously described [49,50] from 20-day-old BALB/c
mouse embryos. For CM enrichment, the cell suspension was preplated in tissue
culture flasks and incubated at 37 °C for 45 min in a 5% CO2 atmosphere, after
which time the culture flasks were gently shaken, and the unattached CMs were
withdrawn with a pipette. The cells were then plated on gelatin-treated 24-well
tissue plates (Corning, Corning, NY, USA), and the medium was replaced daily.
The percentages of CD14+ and CD11b+ cells decreased significantly after cell
preadhesion, reaching values close to 0 (0.57 and 0.04%, respectively) when the
cells were preincubated on uncoated plates for 45 min.
Flow-cytometry analysis
Control or infected CMs were stained with fluorescein isothiocyanate or
phycoerythrin antibodies against Fas and Fas-L (BD Biosciences, Pharmingen,
San Jose, CA, USA) molecules. Cells were analyzed by use of a flow cytometer
and CellQuest software (Becton–Dickinson, Franklin Lakes, NJ, USA).
Cardiac MRI
Cardiac MRI was performed as previously described by our laboratory [22].
Right ventricular internal chamber dimension was determined as previously
described [22]. Statistical significance (pb0.05) was evaluated using ANOVA.
All data are presented as means±SEM.Acknowledgments
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